1 Min Read
Dec 14 (Reuters) - Nanhua Bio Medicine Co Ltd
* Says securities regulator to resume review of its share private placement application
Source text in Chinese: bit.ly/2hswSSP
Further company coverage: (Reporting by Hong Kong newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.